Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 749638
                    [Title] => Diabetes, cancer link is new research focus
                    [Summary] => 
Both diabetes itself and insulin therapy are associated with an increased risk for cancer, but the question of whether insulin glargine — or insulin analogues in general — is associated with a further increased risk remains open, five speakers said at a special symposium during the annual meeting of the European Association for the Study of Diabetes.
                    [DatePublished] => 2011-11-20 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

GLARGINE CAUSES CANCER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 749638
                    [Title] => Diabetes, cancer link is new research focus
                    [Summary] => 
Both diabetes itself and insulin therapy are associated with an increased risk for cancer, but the question of whether insulin glargine — or insulin analogues in general — is associated with a further increased risk remains open, five speakers said at a special symposium during the annual meeting of the European Association for the Study of Diabetes.
                    [DatePublished] => 2011-11-20 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Diabetes, cancer link is new research focus

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | November 20, 2011 - 12:00am

Both diabetes itself and insulin therapy are associated with an increased risk for cancer, but the question of whether insulin glargine — or insulin analogues in general — is associated with a further...

Opinion